直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Don’t You Forget About Me: Petitioner’s Failure to Specifically Demonstrate Material Error Leads to Denial Under § 325(d)

September 22, 2025

Authored and Edited by Devan K.T. Knapp; Umber Aggarwal; Forrest A. Jones

Under the new bifurcated discretionary denial review process, 35 U.S.C. § 325(d) has most often been cited in support of referral due to the need to correct material error by the Office, rather than as a reason for discretionary denial. However, in TankLogix, LLC v. SitePro, Inc., IPR2025-00761, Paper 10 (PTAB Sept. 3, 2025), USPTO Acting Director Coke Morgan Stewart denied institution under § 325(d).

Before addressing § 325(d), the Director concluded the status of the parallel proceeding “neither favor[ed] nor counsel[ed] against discretionary denial” because of the uncertainty whether a final written decision in the IPR would be issued after the district court trial. IPR2025-00761, Paper 10 at 2. The uncertainty arose because the anticipated date for the final written decision, November 19, 2026, fell between the scheduled trial date of October 26, 2026, and statistical projections indicating that the trial could commence in September 2027.

Moving to § 325(d), the Director determined that the four references asserted in the petition were the same as previously presented to the Office during prosecution—three cited by the examiner, and one cited by the applicant. Critically, Petitioner “merely assert[ed] that the Petition ‘details how the references disclose every element of every claim’”—but “[t]his assertion alone [was] insufficient to demonstrate material error by the Office.” IPR2025-00761, Paper 10 at 2-3.

Takeaway

This denial illustrates that, despite the shift in how § 325(d) is being applied, petitioners must still specifically argue how the USPTO erred in evaluating any relied-on references to overcome denial under § 325(d).

 

Tags

discretionary denials

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Atlanta, GA

Reston, VA

Washington, DC

Contacts

Devan K.T. Knapp
Associate
Atlanta, GA
+1 404 653 6456
Email
Umber Aggarwal
Associate
Reston, VA
+1 571 203 2423
Email
Forrest A. Jones
Partner
Washington, DC
+1 202 408 4019
Email

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP